Indocyanine green and Fluorescein sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Indocyanine green (indocyanine green) and Fluorescein sodium (fluorescein sodium). Common drug interactions include low birth weight baby among females and urticaria among males.

The phase IV clinical study analyzes what interactions people have when they take Indocyanine green and Fluorescein sodium. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Indocyanine green?

Indocyanine green has active ingredients of indocyanine green. eHealthMe is studying from 122 Indocyanine green users. Check the latest studies of Indocyanine green.

What is Fluorescein sodium?

Fluorescein sodium has active ingredients of fluorescein sodium. eHealthMe is studying from 269 Fluorescein sodium users. Check the latest studies of Fluorescein sodium.



On Jul, 08, 2026

18 people who take Indocyanine green and Fluorescein sodium together, and have interactions are studied.

Indocyanine green and Fluorescein sodium drug interactions.

What are the common drug interactions of Indocyanine Green and Fluorescein Sodium, by gender? *:

female:

  1. Low birth weight baby
  2. Liver disorder (liver diseases)
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Photocoagulation
  5. Abortion spontaneous (naturally occurring miscarriage)
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Blood alkaline phosphatase increased
  9. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  10. Gamma-glutamyltransferase increased

male:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Age-related macular degeneration
  3. Pruritus generalised (generalized itching)
  4. Rash
  5. Throat irritation
  6. Throat tightness
  7. Vomiting
  8. Cataract (clouding of the lens inside the eye)
  9. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
  10. Visual acuity reduced (reduced clearness of vision)

What are the common drug interactions of Indocyanine Green and Fluorescein Sodium, by age (0-1 to 60+)? *:

0-1:

  1. Low birth weight baby

2-9:

n/a

10-19:

n/a

20-29:

  1. Pruritus (severe itching of the skin)
  2. Rash
  3. Abortion spontaneous (naturally occurring miscarriage)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Nausea (feeling of having an urge to vomit)
  6. Pyrexia (fever)
  7. Skin swelling

30-39:

n/a

40-49:

  1. Pruritus generalised (generalized itching)
  2. Throat tightness
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

n/a

60+:

  1. Age-related macular degeneration
  2. Cataract (clouding of the lens inside the eye)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Blood alkaline phosphatase increased
  6. Gamma-glutamyltransferase increased
  7. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Retinal scar (development of scar tissue on retina)
  10. Visual acuity reduced (reduced clearness of vision)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 5 people, 27.78%
  2. Polypoidal Choroidal Vasculopathy (polyp-like sub-retinal pigment epithelium vascular abnormalities predominantly found in the macula and peripapillary region): 5 people, 27.78%
  3. Hypersensitivity: 5 people, 27.78%
  4. High Blood Pressure: 5 people, 27.78%
  5. Age-Related Macular Degeneration: 5 people, 27.78%
  6. Dyslipidaemia (abnormal amount of lipids): 2 people, 11.11%
  7. Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 1 person, 5.56%
  8. Allergic Rhinitis: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Indocyanine green and Fluorescein sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Indocyanine green and Fluorescein sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Indocyanine green:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluorescein sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Indocyanine green and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluorescein sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on indocyanine green and fluorescein sodium (the active ingredients of Indocyanine green and Fluorescein sodium, respectively), and Indocyanine green and Fluorescein sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: